CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' (DEFICIT) EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Accumulated Deficit
Balance, beginning of period at Jan. 28, 2023	$ 29,773	$ 175,450	$ (145,677)
Balance, beginning of period (in shares) at Jan. 28, 2023		12,754,368
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued (in shares)		86,824
Net share settlement of restricted stock units	(76)	$ (76)
Net share settlement of restricted stock units (in shares)		(28,294)
Stock-based compensation expense	490	$ 490
Net Income (Loss)	(12,107)		(12,107)
Balance, end of period at Apr. 29, 2023	$ 18,080	$ 175,864	(157,784)
Balance, end of period (in shares) at Apr. 29, 2023	12,812,898	12,812,898
Balance, beginning of period at Feb. 03, 2024	$ 3,124	$ 176,552	(173,428)
Balance, beginning of period (in shares) at Feb. 03, 2024	12,926,022	12,926,022
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued (in shares)		134,597
Net share settlement of restricted stock units	$ (51)	$ (51)
Net share settlement of restricted stock units (in shares)		(21,641)
Stock-based compensation expense	292	$ 292
Net Income (Loss)	(8,830)		(8,830)
Balance, end of period at May. 04, 2024	$ (5,465)	$ 176,793	$ (182,258)
Balance, end of period (in shares) at May. 04, 2024	13,038,978	13,038,978